INT343019

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.21
First Reported 2010
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 1.58
Pain Relevance 0.13

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cell differentiation (Azi1)
Azi1 (Mus musculus)
Pain Link Frequency Relevance Heat
abdominal pain 10 66.64 Quite High
imagery 12 5.00 Very Low Very Low Very Low
nud 8 5.00 Very Low Very Low Very Low
Bioavailability 4 5.00 Very Low Very Low Very Low
agonist 4 5.00 Very Low Very Low Very Low
Central nervous system 2 5.00 Very Low Very Low Very Low
Analgesic 2 5.00 Very Low Very Low Very Low
sSRI 2 5.00 Very Low Very Low Very Low
anesthesia 2 5.00 Very Low Very Low Very Low
Calcium channel 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Gastric Motility Disorder 70 100.00 Very High Very High Very High
Dyskinesias 2 80.40 Quite High
Abdominal Pain 10 66.64 Quite High
Myocardial Infarction 10 44.64 Quite Low
Cirrhosis 2 42.36 Quite Low
Lacerations 2 38.16 Quite Low
Umbilical Hernia 2 34.56 Quite Low
Vomiting 16 5.00 Very Low Very Low Very Low
Dyspepsia 8 5.00 Very Low Very Low Very Low
Diabetes Mellitus 6 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
This result supports the use of AZI as a viable alternative to ERY for treating GP, as well as findings from a previous study and case report suggesting a role for AZI in the treatment of GP.35,36 AZI could also be used during provocative testing with GES to evaluate response to this novel prokinetic that has never previously been used in the literature for such a purpose.
Positive_regulation (used) of Positive_regulation (role) of AZI associated with gastric motility disorder
1) Confidence 0.21 Published 2010 Journal Journal of Neurogastroenterology and Motility Section Body Doc Link PMC2978393 Disease Relevance 0.79 Pain Relevance 0.07
This result supports the use of AZI as a viable alternative to ERY for treating GP, as well as findings from a previous study and case report suggesting a role for AZI in the treatment of GP.35,36 AZI could also be used during provocative testing with GES to evaluate response to this novel prokinetic that has never previously been used in the literature for such a purpose.
Positive_regulation (role) of Positive_regulation (treatment) of AZI associated with gastric motility disorder
2) Confidence 0.21 Published 2010 Journal Journal of Neurogastroenterology and Motility Section Body Doc Link PMC2978393 Disease Relevance 0.79 Pain Relevance 0.07

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox